Monkeypox declared public health emergency

The Department of Health and Human Services (HHS) has declared monkeypox a public health emergency (PHE), enabling more federal funds to be thrown at the outbreak.

HHS Secretary Xavier Becerra made the announcement Aug. 4 in recognition of the continued rapid transmission of monkeypox in the U.S. and globally. The move is part of the Biden-Harris administration's strategy on monkeypox, which includes scaling the production and availability of vaccines, expanding testing capacity, reducing burdens in accessing treatments and reaching out to stakeholders and members of the LGBTQ+ community.  The U.S. reported more than 7,100 cases as of Aug. 5, according to the Centers for Disease Control and Prevention (CDC). New York has the highest number of cases in the nation, with 1,748 cases. 

The move by HHS also comes after the World Health Organization (WHO) declared monkeypox a public health emergency at the end of July.

The disease is characterized by a rash that can look like pimples or blisters, fever, headache, muscle aches, swollen lymph nodes, respiratory symptoms and more. The CDC recommends that people who have been exposed to monkeypox and those who are at high risk of being exposed should be vaccinated for the virus.

“Ending the monkeypox outbreak is a critical priority for the Biden-Harris Administration. We are taking our response to the next level by declaring a public health emergency,” said Secretary Becerra. “With today’s declaration we can further strengthen and accelerate our response further.”

By declaring a PHE, the federal government can also implement more data sharing, and 51 jurisdictions have already signed data use agreements to provide the CDC with information related to vaccine administration. The PHE declaration also authorizes the Centers for Medicare and Medicaid Services (CMS) to collect testing and hospitalization.

HHS has shipped more than 602,000 doses of the JYNNEOS vaccine to states and jurisdictions, up from 266,000 last week. The agency has allocated 1.1 million doses and is making more available as current supply is used. HHS will accelerate the delivery of another 150,000 doses to arrive in the U.S. next month.

According to the CDC, monkeypox spreads through close, personal, often skin-to-skin contact. The LGBTQ+ community has been particularly impacted by the spread, though the virus can also be spread by touching objects, fabrics and surfaces that have been used by someone with monkeypox and through respiratory secretions. It can also be spread from infected animals. Scientists are still researching other ways the virus could be spreading, such as when someone shows no symptoms.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.